BC Children’s is home to facilities that are truly world-class—healing environments for kids and their families, and technologically advanced equipment. Delivering the highest level of care also requires having the top medical minds. Last year, donors like you helped BC Children’s recruit and train expert clinicians and researchers. Here’s how:
Hudson Scholars Awards Program
In 2016, the remarkable generosity of the Hudson family allowed BC Children’s to establish its first-ever Hospital Chair, a prestigious honour bestowed upon leadership positions within the hospital. Since then, Dr. Allison Eddy, chief of pediatric medicine and Hudson Family Chair in Pediatric Medicine at BC Children’s, has been given the opportunity to bring her strategic vision to life.
As part of her plan, Dr. Eddy established a mentored career development program, called the Hudson Scholars Awards Program. It’s focused on providing early-career physicians the opportunity to explore the field of quality improvement in medicine, and has quickly established BC Children’s as a leader in this emerging field.
The work of the initial group of scholars enhanced care in 2018 in some noticeable ways. Vaccination tracking practices were enhanced, the discharge process was streamlined, and work is being done to improve care for infants with meningitis.
Now, five new scholars are diving into research designed to tackle important issues—like reducing unnecessary admissions and testing and improving virtual care practices. We can’t wait to update you on their progress.
Last year, your support helped train the next generation of child health experts through fellowships and grants.
Graduate studentships were awarded to researchers working to advance care—such as one that is evaluating an eye movement test that could one day lead to a more effective way to diagnose concussions.
Postdoctoral fellowships also helped researchers advance studies and gain important knowledge. One, for instance, looks to identify ways to stimulate the immune system to attack leukemia cells, which could help kids who don’t respond to current treatments.